Download PDF
Semin Musculoskelet Radiol 2001; 05(1): 043-056
DOI: 10.1055/s-2001-12920
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Magnetic Resonance and Computed Tomography Imaging in Multiple Myeloma

Frederic E. Lecouvet, Bruno C. Vande Berg, Jacques Malghem, Baudouin E. Maldague
  • Department of Radiology and Medical Imaging, Saint Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

ABSTRACT

This article reviews current knowledge on the various lesion patterns that can be observed at magnetic resonance (MR) imaging and on computed tomography images in patients with plasma cell neoplasms. It reviews limitations in specificity of imaging features and emphasizes difficulties in the recognition of the benign or malignant origin of vertebral fractures in these patients. The prognostic significance of MR imaging findings with respect to the natural history of the disease or to survival after treatment is discussed.

KEYWORD

Myeloma - multiple myeloma - plasmocytoma

REFERENCES

  • 1 Terpstra W E, Lokhorst H M, Blomjous F, Meuwissen O J, Dekker A W. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.  Br J Haematol . 1992;  82 46-49
    PubMedGoogle Scholar
  • 2 Greipp P R. Advances in the diagnosis and management of myeloma.  Semin Hematol . 1992;  29 24-45
    PubMedGoogle Scholar
  • 3 Boccadoro M, Pileri A. Diagnosis, prognosis, and standard treatment of multiple myeloma.  Hematol Oncol Clin North Am . 1997;  11 111-131
    CrossrefPubMedGoogle Scholar
  • 4 Salmon S E, Cassady J R. Plasma cell neoplasms. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology Philadelphia, PA: Lippincott 1995: 1984-2024
    Google Scholar
  • 5 Kapadia S B. Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases.  Medicine . 1980;  59 380-392
    PubMedGoogle Scholar
  • 6 Carson C P, Ackerman R. Plasma cell myeloma. A clinical, pathologic and roentgenologic review of 90 cases.  Am J Clin Pathol . 1955;  25 849-887
    PubMedGoogle Scholar
  • 7 Heiser S, Schartzmann J J. Variation in the Roentgen appearance in the skeletal system in myeloma.  Radiology . 1952;  58 178-191
    PubMedGoogle Scholar
  • 8 Kyle R A. Multiple myeloma: review of 869 cases.  Mayo Clin Proc . 1975;  50 29-40
    PubMedGoogle Scholar
  • 9 Moulopoulos L A, Dimopoulos M A, Smith T L, Weber D M, Delasalle K B, Libshitz H I, Alexanian R. Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma.  J Clin Oncol . 1995;  13 251-256
    PubMedGoogle Scholar
  • 10 Vande Berg C B, Lecouvet F E, Michaux L. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.  Radiology . 1996;  201 243-246
    PubMedGoogle Scholar
  • 11 Weber D M, Dimopoulos M A, Moulopoulos L A, Delasalle K B, Smith T, Alexanian R. Prognostic features of asymptomatic multiple myeloma.  Br J Haematol . 1997;  97 810-814
    PubMedGoogle Scholar
  • 12 Davies F E, Jack A S, Morgan G J. The use of biological variables to predict outcome in multiple myeloma.  Br J Haematol . 1997;  99 719-725
    CrossrefPubMedGoogle Scholar
  • 13 Boccadoro M, Pileri A. Prognostic factors in multiple myeloma. In: Malpas JS, Bergsagel DE, Kyle RA, eds. Myeloma: Biology and Management New York: Oxford University Press 1995: 251-270
    Google Scholar
  • 14 Tricot G, Sawyer J R, Jagannath S. Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.  J Clin Oncol . 1997;  15 2659-2666
    PubMedGoogle Scholar
  • 15 Daffner R H, Lupetin A R, Dash N, Deeb Z L, Sefczek R J, Schapiro R L. MRI in the detection of malignant infiltration of bone marrow.  AJR . 1986;  146 353-358
    PubMedGoogle Scholar
  • 16 Rahmouni A, Divine M, Mathieu D. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.  AJR . 1993;  160 1049-1052
    PubMedGoogle Scholar
  • 17 Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser M F. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.  AJR . 1996;  167 1029-1036
    PubMedGoogle Scholar
  • 18 Avrahami E, Tadmor R, Kaplinsky N. The role of T2-weighted gradient echo in MRI demonstration of spinal multiple myeloma.  Spine . 1993;  18 1812-1815
    PubMedGoogle Scholar
  • 19 Ludwig H, Fruhwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E. Magnetic resonance imaging of the spine in multiple myeloma.  Lancet . 1987;  2 364-366
    PubMedGoogle Scholar
  • 20 Moulopoulos L A, Varma D G, Dimopoulos M A. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.  Radiology . 1992;  185 833-840
    PubMedGoogle Scholar
  • 21 Joffe J, Williams M P, Cherryman G R, Gore M, McElwain T J, Selby P. Magnetic resonance imaging in myeloma.  Lancet . 1988;  1 1162-1163
    PubMedGoogle Scholar
  • 22 Cristy M. Active bone marrow distribution as a function of age in humans.  Phys Med Biol . 1981;  26 389-400
    CrossrefPubMedGoogle Scholar
  • 23 Vande Berg C B, Lecouvet F E, Michaux L, Ferrant A, Maldague B, Malghem J. Magnetic resonance imaging of the bone marrow in hematological malignancies.  Eur Radiol . 1998;  8 1335-1344
    CrossrefPubMedGoogle Scholar
  • 24 Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka J T, Melhem E R, Yucel E K. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases.  AJR . 1997;  169 1655-1661
    PubMedGoogle Scholar
  • 25 Lecouvet F E, Vande Berg C B, Michaux L. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.  Radiology . 1998;  209 653-660
    PubMedGoogle Scholar
  • 26 Libshitz H I, Malthouse S R, Cunningham D, MacVicar A D, Husband J E. Multiple myeloma: appearance at MR imaging.  Radiology . 1992;  182 833-837
    PubMedGoogle Scholar
  • 27 Baur A, Stabler A, Bartl R, Lamerz R, Scheidler J, Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration.  Skeletal Radiol . 1997;  2 414-418
    PubMedGoogle Scholar
  • 28 Carlson K, Astrom G, Nyman R, Ahlstrom H, Simonsson B. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment.  Acta Radiol . 1995;  36 9-314
    PubMedGoogle Scholar
  • 29 Lecouvet F E, Malghem J, Michaux L. Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow.  Radiology . 1997;  204 201-205
    PubMedGoogle Scholar
  • 30 Kyle R A, Schreiman J S, McLeod R A, Beabout J W. Computed tomography in diagnosis and management of multiple myeloma and its variants.  Arch Intern Med . 1985;  145 1451-1452
    CrossrefPubMedGoogle Scholar
  • 31 Helms C A, Genant H K. Computed tomography in the early detection of skeletal involvement with multiple myeloma.  JAMA . 1982;  248 2886-2667
    CrossrefPubMedGoogle Scholar
  • 32 Laroche M, Assoun J, Sixou L, Attal M. Comparison of MRI and computed tomography in the various stages of plasma cell disorders: correlations with biological and histological findings. Myelome-Midi-Pyrenees Group.  Clin Exp Rheumatol . 1996;  14 171-176
    PubMedGoogle Scholar
  • 33 Riccardi A, Gobbi P G, Ucci G, Bertoloni D, Luoni R, Rutigliano L, Ascari E. Changing clinical presentation of multiple myeloma.  Eur J Cancer . 1991;  27 1401-1405
    PubMedGoogle Scholar
  • 34 Spiess J L, Adelstein D J, Hines J D. Multiple myeloma presenting with spinal cord compression.  Oncology . 1988;  45 88-92
    PubMedGoogle Scholar
  • 35 Moulopoulos L A, Dimopoulos M A. Magnetic resonance imaging of the bone marrow in hematologic malignancies.  Blood . 1997;  90 2127-2147
    PubMedGoogle Scholar
  • 36 Cuenod C A, Laredo J D, Chevret S. Acute vertebral collapse due to osteoporosis or malignancy: appearance on unenhanced and gadolinium-enhanced MR images.  Radiology . 1996;  199 541-549
    PubMedGoogle Scholar
  • 37 Moulopoulos L A, Yoshimitsu K, Johnston D A, Leeds N E, Libshitz H I. MR prediction of benign and malignant vertebral compression fractures.  J Magn Reson Imaging . 1996;  6 667-674
    PubMedGoogle Scholar
  • 38 Lecouvet F E, Vande Berg C B, Maldague B E. Vertebral compression fractures in multiple myeloma. Part I. Distribution and appearance at MR imaging.  Radiology . 1997;  204 195-199
    PubMedGoogle Scholar
  • 39 Fruehwald F X, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek P C. Magnetic resonance imaging of the lower vertebral column in patients with multiple myeloma.  Invest Radiol . 1988;  23 193-199
    PubMedGoogle Scholar
  • 40 Resnick D, Niwayama G, Guerra Jr J, Vint V, Usselman J. Spinal vacuum phenomena: anatomical study and review.  Radiology . 1981;  139 341-348
    CrossrefPubMedGoogle Scholar
  • 41 Durie B G, Salmon S E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.  Cancer . 1975;  36 842-854
    CrossrefPubMedGoogle Scholar
  • 42 de Gramont A, Benitez O, Brissaud P. Quantification of bone lytic lesions and prognosis in myelomatosis.  Scand J Haematol . 1985;  34 78-82
    PubMedGoogle Scholar
  • 43 Tertti R, Alanen A, Remes K. The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine.  Br J Haematol . 1995;  91 658-660
    CrossrefPubMedGoogle Scholar
  • 44 Lecouvet F E, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux J L, Vande Berg C B. Skeletal survey in multiple myeloma: radiographic versus MR imaging survey.  Br J Haematol . 1999;  106 35
    CrossrefPubMedGoogle Scholar
  • 45 Lecouvet F E, Vande Berg C B, Michaux L, Jamart J, Maldague B E, Malghem J. Development of vertebral fractures in patients with multiple myeloma: does MRI enable recognition of vertebrae that will collapse?.  J Comput Assist Tomogr . 1998;  22 430-436
    CrossrefPubMedGoogle Scholar
  • 46 Corwin J, Lindberg R D. Solitary plasmacytoma of bone versus extramedullary plasmacytoma and their relationship to multiple myeloma.  Cancer . 1979;  43 1007-1013
    CrossrefPubMedGoogle Scholar
  • 47 Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases.  Cancer . 1981;  48 845-851
    PubMedGoogle Scholar
  • 48 Moulopoulos L A, Dimopoulos M A, Weber D, Fuller L, Libshitz H I, Alexanian R. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone.  J Clin Oncol . 1993;  11 1311-1315
    PubMedGoogle Scholar
  • 49 Gregory W M, Richards M A, Malpas J S. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials.  J Clin Oncol . 1992;  10 334-342
    PubMedGoogle Scholar
  • 50 Boccadoro M, Palumbo A, Argentino C. Conventional induction treatments do not influence overall survival in multiple myeloma.  Br J Haematol . 1997;  96 333-337
    CrossrefPubMedGoogle Scholar
  • 51 Attal M, Harousseau J L. Standard therapy versus autologous transplantation in multiple myeloma.  Hematol Oncol Clin North Am . 1997;  11 133-146
    CrossrefPubMedGoogle Scholar
  • 52 Attal M, Harousseau J L, Stoppa A M. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome.  N Engl J Med . 1996;  335 91-97
    CrossrefPubMedGoogle Scholar
  • 53 Barlogie B, Jagannath S, Vesole D H. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.  Blood . 1997;  89 789-793
    PubMedGoogle Scholar
  • 54 Barlogie B, Jagannath S, Desikan K R. Total therapy with tandem transplants for newly diagnosed multiple myeloma.  Blood . 1999;  93 55-65
    PubMedGoogle Scholar
  • 55 Rahmouni A, Divine M, Mathieu D, Golli M, Haioun C, Dao T, Anglade M C, Reyes F, Vasile N. MR appearance of multiple myeloma of the spine before and after treatment.  AJR . 1993;  160 1053-1057
    PubMedGoogle Scholar
  • 56 Moulopoulos L A, Dimopoulos M A, Alexanian R, Leeds N E, Libshitz H I. Multiple myeloma: MR patterns of response to treatment.  Radiology . 1994;  193 441-446
    CrossrefPubMedGoogle Scholar
  • 57 Lecouvet F E, De Nayer P, Garbar C, Noel H, Malghem J, Maldague B E, Vande Berg C B. Treated plasma cell lesions of bone with MRI signs of response to treatment: unexpected pathological findings.  Skeletal Radiol . 1998;  27 692-695
    CrossrefPubMedGoogle Scholar
  • 58 Lecouvet F, Richard F, Vande Berg B. Long-term effects of localized spinal radiation therapy on vertebral fractures and focal lesions appearance in patients with multiple myeloma.  Br J Haematol . 1997;  96 743-745
    CrossrefPubMedGoogle Scholar
  • 59 Agren B, Rudberg U, Isberg B, Svensson L, Aspelin P. MR imaging of multiple myeloma patients with bone-marrow transplants.  Acta Radiol . 1998;  39 36-42
    PubMedGoogle Scholar
  • 60 Angtuaco E J, Avva R, Munshi C N, Peterson R N, Spoon D, Barlogie B. MR skeletal survey of the axial skeleton: a predictor of patient survival in multiple myeloma?.  Radiology . 1999;  213 294
    PubMedGoogle Scholar
      >